Abstract
Introduction

Brain metastasis from hepatocellular carcinoma (HCC) is rare (1) and the prognosis of affected patients is poor (2-4). Therapy for the condition is difficult, because of the poor prognosis, as the short life expectancy at the time diagnosis of brain metastasis makes it difficult to perform aggressive treatment such as surgery, which is invasive, or radiation therapy, which requires time.tumors in the brain and lung showed an accumulation of 99m
Tc-PMT (Fig. 1B (8) 
F i g u r e 1 . A: Ch e s t CT i ma g e s h o wi n g p r o g r e s s i o n o f l u n g me t a s t a s i s ( Au g u s t 2 0 0 7 ) . B : T h e b r a i n t u mo r wa s d i a g n o s e d a s me t a s t a s i s f r o m HCC u s i n g 9 9 m T c -P MT ( p y r i d o x a l -5 -me t h l y -t r i p t op h a n ) s c i n t i g r a p h y . C. B r a i n me t a s t a s i s wa s t r e a t e d u s i n g a c y b e r -k n i f e ( Cy b e r k n i f e I I ) .
F i g u r e 2 . A: E n h a n c e d h e a d CT i ma g e o b t a i n e d a t a d mi s s i o n s h o wi n g a b r a i n t u mo r wi t h i n t r ac r a n i a l h e mo r r h a g e . B : E n h a n c e d h e a d CT i ma g e o b t a i n e d 3 we e k s a f t e r t r e a t me n t wi t h c y b e rk n i f e .
T a b l e 1 . L a b o r a t o r y Da t a Ob t a i n e d a t Ad mi s s i o n
Patients with brain metastasis from HCC have a poor prognosis, with some authors reporting that the survival period after diagnosis is less than 3 months (2-4). Intracranial hemorrhage was found to be the first manifestation in 33% of patients with brain metastasis from HCC (4) and these tumors are known to easily rupture. Patchell et al reported that the characteristics of potential candidates for surgical resection are a single surgically acceptable symptomatic tumor and those with brain metastasis have a life expectancy of at least 2 months (7). The present patient did not hope for surgical resection. In addition, Chang et al (4) and Yen et al
